These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24266011)

  • 1. Prognostic factors following surgical resection of distal bile duct cancer.
    Chung YJ; Choi DW; Choi SH; Heo JS; Kim DH
    J Korean Surg Soc; 2013 Nov; 85(5):212-8. PubMed ID: 24266011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Distal Bile Duct Carcinoma After Surgery.
    Kawahara R; Midorikawa R; Taniwaki S; Kojima S; Kanno H; Yoshitomi M; Nomura Y; Goto Y; Satou T; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Sakaue T; Ushijima T; Yasumoto M; Okabe Y; Tanigawa M; Naitou Y; Yano H; Okuda K
    Kurume Med J; 2023 Jul; 68(2):81-89. PubMed ID: 37005293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection.
    Park Y; Hwang DW; Kim JH; Hong SM; Jun SY; Lee JH; Song KB; Jun ES; Kim SC; Park KM
    J Hepatobiliary Pancreat Sci; 2019 May; 26(5):169-178. PubMed ID: 30849218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
    Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects.
    Lim SY; Alramadhan HJ; Jeong H; Chae H; Kim HS; Yoon SJ; Shin SH; Han IW; Heo JS; Kim H
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
    Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
    Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
    Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
    Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of relapse and long-term survival between pylorus-preserving and Whipple pancreaticoduodenectomy in periampullary cancer.
    Takao S; Aikou T; Shinchi H; Uchikura K; Kubo M; Imamura H; Maenohara S
    Am J Surg; 1998 Nov; 176(5):467-70. PubMed ID: 9874435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.
    Yoshida T; Matsumoto T; Sasaki A; Morii Y; Aramaki M; Kitano S
    Arch Surg; 2002 Jan; 137(1):69-73. PubMed ID: 11772220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.
    Kim DH; Choi DW; Choi SH; Heo JS
    Ann Surg Treat Res; 2014 Aug; 87(2):94-9. PubMed ID: 25114889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatoduodenectomy for bile duct and ampullary cancer.
    Yamaguchi K
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):210-5. PubMed ID: 22170385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical strategy for bile duct cancer: Advances and current limitations.
    Akamatsu N; Sugawara Y; Hashimoto D
    World J Clin Oncol; 2011 Feb; 2(2):94-107. PubMed ID: 21603318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.